FilingReader Intelligence
NRC Corporation establishes pharmaceutical subsidiary with 50bn dong
August 14, 2025 at 06:00 PM UTC•By FilingReader AI
NRC Corporation has established NRC Pharma Co., Ltd. with charter capital of 50 billion dong, marking the company's expansion into the pharmaceutical sector.
The new subsidiary will engage in pharmaceutical manufacturing and retail, medical equipment, and wholesale of medical products.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HNX:NRC•Hanoi Stock Exchange
News Alerts
Get instant email alerts when Danh Khoi Group Joint Stock Company publishes news
Free account required • Unsubscribe anytime